Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Malvern, Pennsylvania
- Most recent report
- 8-K, filed Oct 20, 2026
- Incorporated
- Delaware
- Filings on record
- 308 filings
- On EDGAR
- CIK 1477845
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 27
News 8 of 82
Prospectuses and Registrations 8 of 33
- 424B5 Prospectus supplement for an offering May 20, 2026
- 424B5 Prospectus supplement for an offering May 19, 2026
- 424B5 Prospectus supplement for an offering Apr 9, 2026
- 424B5 Prospectus supplement for an offering Oct 28, 2025
- 424B5 Prospectus supplement for an offering Oct 14, 2025
- 424B5 Prospectus supplement for an offering Feb 4, 2025
- 424B5 Prospectus supplement for an offering Feb 3, 2025
- 424B5 Prospectus supplement for an offering Dec 11, 2024
Proxies 8 of 19
- DEFA14A Extra proxy material Oct 7, 2026
- DEF 14A Proxy statement for a shareholder vote Sep 11, 2026
- PRE 14A Preliminary proxy statement Aug 25, 2026
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEFA14A Extra proxy material May 1, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEFA14A Extra proxy material May 6, 2024
Ownership 8 of 103
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 15, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 29, 2026
- 4 Insider reported a trade May 21, 2026
- 4 Insider reported a trade Apr 3, 2026
- 144 Notice of a proposed sale of restricted stock Apr 2, 2026
- 4 Insider reported a trade Dec 8, 2025
- 4/A Insider reported a trade, amended Nov 25, 2025
Other 8 of 44
- UPLOAD Comment letter from SEC staff Sep 30, 2025
- CORRESP Reply to SEC staff Sep 29, 2025
- CORRESP Reply to SEC staff Sep 19, 2025
- UPLOAD Comment letter from SEC staff Sep 4, 2025
- ARS Annual report sent to shareholders May 1, 2025
- ARS Annual report sent to shareholders Apr 29, 2024
- EFFECT Notice that a registration became effective Feb 12, 2024
- CORRESP Reply to SEC staff Feb 9, 2024
Everything here comes from Annovis Bio, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.